Back
HFA Premium Access

Are women being offered an ICD compare to men ?

Session: Poster Session 1 - Device Therapy
Topic: Implantable Cardioverter-Defibrillator (ICD)
Speaker: Doctor S. Lepage (Sherbrooke, CA)
Event: Heart Failure 2019

Congress Presentation

About the speaker

Doctor Serge Lepage

Sherbrooke University, Sherbrooke (Canada)
0 follower

10 more presentations in this session

Low heart rate at follow up predicts improvement of ejection fraction in a large-volume cohort of women with wearable cardioverter defibrillator

Speaker: Doctor L. Schrutka (Vienna, AT)

Access
Abstract
Slides
Thumbnail

Epicardial adipose tissue echocardiographic thickness predicts arrhythmic outcome in heart failure patients.

Speaker: Doctor L. Ferrante (Vicenza, IT)

Access
Abstract
Thumbnail

The prevalence of anxiety among patients with implantable cardioverter-defibrillator, does it change with decades of implementations?

Speaker: Associate Professor R. Olszewski (Warsaw, PL)

Access
Abstract
Thumbnail

Single lead implantable cardioverter-defibrillator lead system with a atrial sensing dipole (Dx-AICD technology): 1-year follow-up

Speaker: Doctor P. Sangoi (Chennai, IN)

Access
Abstract
Slides
Thumbnail

Appropriate and inappropriate ICD therapy in patients with ischemic and non-ischemic cardiomyopathies according remote monitoring data.

Speaker: Mr D. Losik (Limassol, CY)

Access
Slides
Thumbnail

Access the full session

Poster Session 1 - Device Therapy

Speakers: Doctor S. Lepage, Doctor L. Schrutka, Doctor L. Ferrante, Associate Professor R. Olszewski, Doctor P. Sangoi...
Access
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb